Suggestions
Goetz Gerecke
Managing Director & Senior Partner, Global Medtech Commercial Leader, Boston Consulting Group (BCG)
Professional Background
Goetz Gerecke is a highly accomplished Managing Director and Senior Partner at the prestigious Boston Consulting Group (BCG) in Zurich. With a remarkable career spanning nearly three decades, Goetz joined BCG in 1995 in their London office, where he quickly established himself as an invaluable member of the firm’s Health Care Practice. He currently heads the firm’s Medtech Commercial Business on a global scale and is also the leader of BCG's Marketing, Sales & Pricing Practice in Switzerland. His extensive expertise in the medtech, biopharma, and private equity industries has solidified his reputation as a leader in commercial strategy and business transformation.
Goetz's core focus lies in generating growth for his clients, a passion that permeates his work. He has been instrumental in developing go-to-market strategies and transforming commercial models, which are essential for success in today's competitive landscape. Furthermore, he is recognized for his work in driving large-scale change, lean management, and business model innovation, setting a high standard for excellence in commercial practices.
In addition to his consulting roles, Goetz also serves as a Board Member of the Centre for Public Impact, a foundation established by BCG, which aims to improve the effectiveness of public services. This role reflects his commitment to leveraging his extensive experience to contribute positively to society through impactful initiatives. He has previously served as a Co-Founder and Managing Partner at Wellness Business Partners, Principal at Compass Partners Advisors, LLP, and Project Leader at BCG.
Education and Achievements
Goetz Gerecke’s educational background is equally impressive, marked by his achievements at esteemed institutions. He earned his Master of Business Administration (MBA) from Harvard Business School, a program renowned for cultivating innovative and strategic thinkers in the business world. Prior to that, he obtained a Bachelor of Science (BSc) from EBS Universität für Wirtschaft und Recht, where he laid the foundation for his future endeavors in business and consulting.
His academic credentials complement his professional experience, equipping him with the skills necessary to advise major players in the health care and biopharma industries effectively. Goetz’s long-standing career at BCG has allowed him to engage with numerous high-profile clients, guiding them through complex challenges and enabling them to realize significant growth opportunities.
Notable Achievements
Goetz's extensive career is marked by several notable achievements and contributions to the consulting industry. His leadership in BCG's various practices exemplifies his capability to navigate the complexities of both medical technology and commercial excellence, making him a sought-after expert in these fields.
Some of his notable achievements include:
- Leading BCG’s Medtech Commercial Business worldwide, where he applies his deep understanding of the healthcare landscape to drive client success.
- Developing innovative commercial strategies and frameworks for clients in the medtech and biopharma sectors that have resulted in substantial growth and improved market positioning.
- Spearheading initiatives related to lean management and organizational transformation that enhance operational efficiency and performance.
- Actively participating as a Board Member at the Centre for Public Impact, where his insights and experience help shape public policy and improve service delivery initiatives globally.
- Contributing to industry thought leadership through various engagements, discussions, and workshops that advance best practices in marketing, sales, and pricing.
Goetz Gerecke remains a pivotal figure in consulting, blending deep industry knowledge with an unwavering commitment to helping clients achieve their goals. His leadership at BCG, combined with a robust educational background from Harvard Business School, underscores his position as a trusted advisor in the health care and biopharma sectors.
